Evidence map›Paper›PMID 39738971›Full record

ArticleActa neurologica Belgica2025

Clinical features and prognosis of transient global amnesia in Israel: 6 years' single-center experience.

Ido Gindes, Itzhak Kimiagar, Shlomi Peretz, Gilad Kenan

Abstract read
In one paragraph

Article in Acta neurologica Belgica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ido GindesTel-Aviv university, Tel Aviv-Yafo, Israel.
Itzhak KimiagarDepartment of Neurology, Shamir Medical Center, Be`er Ya`akov, Israel.
Shlomi PeretzDepartment of Neurology, Shamir Medical Center, Be`er Ya`akov, Israel.
Gilad KenanDepartment of Neurology, Shamir Medical Center, Be`er Ya`akov, Israel. giladankori@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTransient global amnesia (TGA) is a benign neurological syndrome of unknown etiology, causing sudden anterograde amnesia that lasts up to 24 h. During the episode of TGA, other cognitive functions are normal. This is the first study describing the characteristics of the disease in Israel.

methodsA retrospective review of all patients with a confirmed diagnosis of TGA at Shamir Medical Center (SMC) between January 2016 and December 2021.

resultsOne-hundred and four patients with confirmed TGA were identified, with an average age of 64 years (range: 39-87). The annual incidence of TGA was 2.52 per 100,000 and 6.96 per 100,000 among those over 50, with a slight female predominance. The recurrence rate was 11.5%. 61.5% of patients had one or more cerebrovascular risk factors. A precipitating factor was described in 30.8% of cases, with emotional stress, Valsalva maneuver and sexual intercourse being the most prevalent. Chronic ischemic changes were the most common imaging abnormality. Focal slowing was found in nine patients, and epileptic activity was found in four patients.

conclusionsIn this study, we showed that patient characteristics and clinical features of TGA patients in Israel were similar to those described in other reports worldwide. We were unable to demonstrate a specific risk factor or a causative agent. Interestingly, the annual incidence in Israel was lower than in other countries.

Indexed as

Amnesia, Transient GlobalAdultAgedAged, 80 and overFemaleHumansIncidenceIsraelMaleMiddle AgedPrognosisRetrospective StudiesRisk FactorsAmnesiaEpidemiologyIncidenceIsraelPathogenesisTGATransient global amnesia

Identifiers

PMID39738971
PMCPMC12014766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.